翻訳と辞書
Words near each other
・ HIV superinfection
・ HIV trial in Libya
・ HIV tropism
・ HIV vaccine
・ HIV Vaccine Trials Network
・ Hiv, Iran
・ HIV-1 protease
・ HIV-2 retropepsin
・ HIV-affected community
・ HIV-associated lipodystrophy
・ HIV-associated nephropathy
・ HIV-associated neurocognitive disorder
・ HIV-associated pruritus
・ HIV-mobil
・ HIV-positive people
HIV-tainted blood scandal (Japan)
・ HIV/AIDS
・ HIV/AIDS Bureau
・ HIV/AIDS denialism
・ HIV/AIDS denialism in South Africa
・ HIV/AIDS in Africa
・ HIV/AIDS in Angola
・ HIV/AIDS in Argentina
・ HIV/AIDS in Asia
・ HIV/AIDS in Australia
・ HIV/AIDS in Bangladesh
・ HIV/AIDS in Benin
・ HIV/AIDS in Bhutan
・ HIV/AIDS in Bolivia
・ HIV/AIDS in Botswana


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

HIV-tainted blood scandal (Japan) : ウィキペディア英語版
HIV-tainted blood scandal (Japan)

The , refers to an event in the 1980s when between one and two thousand haemophilia patients in Japan contracted HIV via tainted blood products. Controversy centered on the continued use of non-heat-treated blood products after the development of heat treatments that prevented the spread of infection. Some high-ranking officials in the Ministry of Health and Welfare, executives of the manufacturing company and a leading doctor in the field of haemophilia study were charged for involuntary manslaughter.
==Background==

Acquired Immune Deficiency Syndrome, or AIDS, is a communicable disease caused by the Human Immunodeficiency Virus, HIV. AIDS is not curable. The first recognition of the emergence of an AIDS-like disease occurred in Los Angeles in 1981.
It was not until 1985 that the first cases of AIDS were officially reported in Japan. As early as 1983, however, Japan's Ministry of Health and Welfare was notified by Baxter Travenol Laboratories (BTL) that it was manufacturing a new blood product, licensed by the U.S. Food and Drug Administration (FDA), which was heat-treated to kill HIV. BTL was interested in licensing this new product in Japan. The Japanese Green Cross Corporation (ミドリ十字), the main Japanese provider of blood products, protested that this would constitute unfair competition, as it was "not prepared to make heat-treated agents itself".〔Leflar, Robert B. "Cancer, AIDS and the Medical Information Fulcrum," Japan Quarterly, vol. 44. April–June 1997.〕 The Ministry of Health responded by ordering screening of untreated blood products, clinical trials of heat-treatments, and a campaign to increase domestic blood donations. The Green Cross Corporation meanwhile distributed letters of "safety assurance of unheated blood products" to patients, many of whom suffered from haemophilia.〔()
* Miyamoto, Masao. "Castration, the HIV Scandal." Speech. Massachusetts Institute of Technology. Cambridge, Mass: April 10, 1996.〕

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「HIV-tainted blood scandal (Japan)」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.